Results 111 to 120 of about 69,990 (168)

[Our Experience with Pediatric Patients Withdrawn from Pharmacological Treatment for Epilepsy who Remain Untreated]. [PDF]

Rev Neurol
López Pisón J, Gómez Sánchez C, Morte Coscolín P, Fariña Jara MV, Martínez Calvo F, Fernando Martínez R.   +5 more
europepmc   +1 more source

[New perspectives in the pharmacological treatment of COPD]. [PDF]

Aten Primaria
Simonet PJ.
europepmc   +1 more source

[Clinical characteristics and pharmacological treatment of patients with heart failure in a primary health care cohort]. [PDF]

Aten Primaria
Giner-Soriano M, Monfà R, Vives R, Fernández-García S, Vallano A, Morros R.   +5 more
europepmc   +1 more source

[2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the AmericasDiretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na região das Américas]. [PDF]

Rev Panam Salud Publica, 2022
Campbell NRC, Paccot Burnens M, Whelton PK, Angell SY, Jaffe MG, Cohn J, Espinosa Brito A, Irazola V, Brettler JW, Roccella EJ, Maldonado Figueredo JI, Rosende A, Ordunez P.   +12 more
europepmc   +1 more source

[Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience]. [PDF]

Rev Neurol
Morte-Coscolín P, Gómez-Sánchez C, López-Pisón J, Fariña-Jara MV, Martínez-Calvo FF, Fernando-Martínez R.   +5 more
europepmc   +1 more source

Pharmacological treatment of patients with chronic heart failure. Subanalysis of an Ecuadorian registry. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Moreno-Rondón L, Ortega-Armas ME, Pulla D, Alarcón Cedeño R, Díaz Heredia J, Villavicencio D, Luces-Tejada O, Gómez M, Castro-Mejía A.   +8 more
europepmc   +1 more source

[Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of type 2 diabetic patients]. [PDF]

Aten Primaria
Canadell-Vilarrasa L, Palanques-Pastor T, Campabadal-Prats C, Salom-Garrigues C, Conde-Giner S, Bejarano-Romero F.   +5 more
europepmc   +1 more source

[Pharmacological treatment in uncertainty times: Hydroxychloroquine/chloroquine use in the COVID-19 treatment]. [PDF]

Semergen, 2020
Mayayo-Vicente S, Rodriguez Salvanés F, Gallego-Arenas A, Sánchez-Gómez LM, Ruiz-López M, Sierra García B, Jurado-López A, Arriola-Bolado P, Cervera Cano M, Novella-Arribas B.   +9 more
europepmc   +1 more source

Factors associated with adherence to antihypertensive agents in the older adult. [PDF]

Rev Cuid
Silva Fhon JR, Gómez-Luján MDP, Caetano GM, Cáceda-Ñazco GS, Pereira Dos Santos-Neto A, Leitón-Espinoza ZE.   +5 more
europepmc   +1 more source

[2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the Region of the AmericasDirectrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas]. [PDF]

Rev Panam Salud Publica, 2022
Campbell NRC, Paccot Burnens M, Whelton PK, Angell SY, Jaffe MG, Cohn J, Espinosa Brito A, Irazola V, Brettler JW, Roccella EJ, Maldonado Figueredo JI, Rosende A, Ordunez P.   +12 more
europepmc   +1 more source